Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lignocaine for Hemodynamic Responses During Intubation in Cardiac Surgery
NCT07611890Phase 4Recruiting
- Sponsor
- Rawalpindi Institute of Cardiology
- Start
- May 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and lidocaine (2 arms), sponsored by Rawalpindi Institute of Cardiology. Primary endpoints: Mean Arterial Pressure at 10 months and Heart Rate at 10 months. Started May 2026; status: recruiting.
02
Drugs
dexmedetomidinelidocaine
Beyond the preview
Go deeper on NCT07611890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07611890.